Shares of Sorrento Therapeutics fell by a staggering 21.73% in 7 days from $9.47 to $7.41 at 12:37 EST on Tuesday, after four consecutive sessions in a row of losses. NASDAQ Composite is dropping 2.58% to $13,536.07, after two sequential sessions in a row of losses.

Sorrento Therapeutics’s last close was $7.91, 161.67% below its 52-week high of $19.39.

Sorrento Therapeutics’s Sales

Sorrento Therapeutics’s sales growth is 123.4% for the present quarter and 119.1% for the next. The company’s growth estimates for the current quarter and the next is 205.6% and 213.9%, respectively.

Sorrento Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 11.7%, now sitting on 39.99M for the twelve trailing months.

Sorrento Therapeutics’s Stock Yearly Top and Bottom Value

Sorrento Therapeutics’s stock is valued at $7.41 at 12:37 EST, way under its 52-week high of $19.39 and way higher than its 52-week low of $2.18.

Sorrento Therapeutics’s Moving Average

Sorrento Therapeutics’s value is way under its 50-day moving average of $10.00 and way below its 200-day moving average of $9.31.

More news about Sorrento Therapeutics.


Please enter your comment!
Please enter your name here